To develop and manufacture safe, effective and competitive means of prevention and treatment of infectious diseases in the domestic and world markets.
Figures and Facts
Production capacity up to 35 million doses of influenza vaccine per year
> 1000 highly qualified employees
The production meets international quality standards
The first Russian exporter of influenza vaccines to non-CIS countries
Leading manufacturer of influenza vaccines for the national calendar of preventive vaccinations of the Russian Federation
Successful experience in biotechnology since 1938
SPbSRIVS interacts with leading vaccine developers within the framework of international organizations:
DCVMN (Developing Countries Vaccine Manufacturers’ Network)
IFPMA (International Federation of Pharmaceutical Manufacturers and Associations)
IVC (Association of Influenza Vaccine Suppliers)
The enterprise is included in the list of organizations that have a significant impact on the industries and trade of the Russian Federation and in the list of systemic enterprises of the pharmaceutical and healthcare industries in St. Petersburg.
SPbSRIVS experts take an active part in the implementation of a number of approaches at the WHO level to countering COVID-19 caused by SARS-CoV-2 and are part of WHO working groups, such as: seroepidemiology, animal models, vaccine target product profile, clinical trials core protocol and comparative characteristics of candidate vaccines.